Skip to main content
  • Clinical
      |Clinical
    • Acute Coronary Syndromes
    • Cardiac Surgery
    • Covid-19
    • Heart Failure
    • Heart Health
    • Heart Rhythm
    • Hypertension
    • Interventional Cardiology
    • Mitral Valve
    • Pharmaceutics
    • Structural Heart Disease
    • TAVR
    • Tricuspid Valve
    • Vascular & Endovascular
  • Management
      |Management
    • Chest Pain Guidelines
    • Compensation
    • Economics
    • Education & Training
    • Legal News
    • Patient Care
    • Policy & Regulations
    • Professional Associations
    • Quality
    • Revenue
    • Staffing
  • Technology
      |Technology
    • AI
    • Cardiac Imaging
    • Cath Lab
    • CT
    • CVIS
    • ECG
    • Echo
    • EP Lab
    • Informatics
    • MRI
    • Nuclear Cardiology
    • Remote Monitoring
  • Videos
  • Conferences
      |Conferences
    • ACC
    • AHA
    • ASE
    • ASNC
    • ESC
    • EuroPCR
    • HFSA
    • HRS
    • SCAI
    • SCCT
    • SIIM
    • SNMMI
    • STS
    • TCT
    • VIVA
  • Custom Content
      |Custom Content
    • Experience Stories
    • Webinars & Videos
  • Subscribe
  • Forty Under 40 Award
      |Forty Under 40 Award
    • Class of 2026
    • Class of 2025

Search form

Home

ASNC ready to fight against cuts | Plant-based diets linked to many benefits | Boston Scientific inks $88M deal | CRF's new hire

News You Need to Know Today
ASNC ready to fight against cuts | Plant-based diets linked to many benefits | Boston Scientific inks $88M deal | CRF's new hire
Thursday, September 11, 2025
Link to Twitter Link to Facebook Link to Linkedin Link to Vimeo

Today's News and Trends

ASNC calls on members to fight 57% Medicare cut for cardiac amyloid imaging

Jamieson M. Bourque, MD, MHS, president-elect of the American Society of Nuclear Cardiology, shared the group's concerns with Cardiovascular Business. “This is going to have a highly negative impact," he said. 

READ MORE >
American Society of Nuclear Cardiology (ASNC) President-elect Jamieson M. Bourque, MD, MHS, FASNC, medical director of nuclear cardiology, echocardiography, and the stress laboratory at UVA Health in Charlottesville, and a professor of medicine and radiology at the University of Virginia, said the society is fighting a major proposed cut in CMS reimbursements in 2026.
Share on Twitter Share on Facebook Share on Linkedin

ASNC calls on members to fight 57% Medicare cut for cardiac amyloid imaging

Share on Twitter Share on Facebook Share on Linkedin
American Society of Nuclear Cardiology (ASNC) President-elect Jamieson M. Bourque, MD, MHS, FASNC, medical director of nuclear cardiology, echocardiography, and the stress laboratory at UVA Health in Charlottesville, and a professor of medicine and radiology at the University of Virginia, said the society is fighting a major proposed cut in CMS reimbursements in 2026.
Jamieson M. Bourque, MD, MHS, president-elect of the American Society of Nuclear Cardiology, shared the group's concerns with Cardiovascular Business. “This is going to have a highly negative impact," he said. 
READ MORE >

Plant-based diets linked to lower risks of death, heart disease, stroke and diabetes

Diets that prioritize plant-based foods are associated with several health benefits, according to a new study of more than 3.4 million adults. Such diets also show potential to reduce greenhouse gas emissions.

READ MORE >
diet nuts legumes vegetables vegan vegetarian plant-based
Share on Twitter Share on Facebook Share on Linkedin

Plant-based diets linked to lower risks of death, heart disease, stroke and diabetes

Share on Twitter Share on Facebook Share on Linkedin
diet nuts legumes vegetables vegan vegetarian plant-based
Diets that prioritize plant-based foods are associated with several health benefits, according to a new study of more than 3.4 million adults. Such diets also show potential to reduce greenhouse gas emissions.
READ MORE >

Boston Scientific to purchase Elutia’s drug-eluting envelope business for $88M

The FDA-cleared EluPro bioenvelope delivers two antibiotics to patients over an extended period of time after they receive an implantable pacemaker or defibrillator to cut infection rates.

READ MORE >
money business cash flow dollar. Kingsway Financial Services, a Chicago-based holding company with subsidiaries in several industries, has acquired New Jersey-based Digital Diagnostics Imaging (DDI) for $11 million. The transaction was funded with $5.4 million in cash and $5.6 million in debt financing.
Share on Twitter Share on Facebook Share on Linkedin

Boston Scientific to purchase Elutia’s drug-eluting envelope business for $88M

Share on Twitter Share on Facebook Share on Linkedin
money business cash flow dollar. Kingsway Financial Services, a Chicago-based holding company with subsidiaries in several industries, has acquired New Jersey-based Digital Diagnostics Imaging (DDI) for $11 million. The transaction was funded with $5.4 million in cash and $5.6 million in debt financing.
The FDA-cleared EluPro bioenvelope delivers two antibiotics to patients over an extended period of time after they receive an implantable pacemaker or defibrillator to cut infection rates.
READ MORE >

Cardiologist Carlos Collet takes new leadership role with CRF

Collet, known globally for his dedication to innovation, is the organization's new director of cardiovascular imaging, physiology and translational therapeutics.

READ MORE >
Carlos Collet, MD, PhD, (center) and colleagues perform CT-guided PCI. Image courtesy of CoreAalst.
Share on Twitter Share on Facebook Share on Linkedin

Cardiologist Carlos Collet takes new leadership role with CRF

Share on Twitter Share on Facebook Share on Linkedin
Carlos Collet, MD, PhD, (center) and colleagues perform CT-guided PCI. Image courtesy of CoreAalst.
Collet, known globally for his dedication to innovation, is the organization's new director of cardiovascular imaging, physiology and translational therapeutics.
READ MORE >

Featured Articles

First study of its kind to focus on new therapy for hypoplastic left heart syndrome

The new trial represents a potential breakthrough in the treatment of one of the most devastating congenital heart defects.

READ MORE >
Joshua M. Hare, MD, FACC, FAHA, a professor of medicine, molecular and cellular pharmacology, and biomedical engineering, director of regenerative medicine, and director of the Interdisciplinary Stem Cell Institute (ISCI) at the University of Miami, and co-founder and chief science officer for the stem cell start-up Longeveron, explains the FDA trial for laromestrocel (Lomecel-B) to treat hypoplastic left heart syndrome (HLHS).
Share on Twitter Share on Facebook Share on Linkedin

First study of its kind to focus on new therapy for hypoplastic left heart syndrome

Share on Twitter Share on Facebook Share on Linkedin
Joshua M. Hare, MD, FACC, FAHA, a professor of medicine, molecular and cellular pharmacology, and biomedical engineering, director of regenerative medicine, and director of the Interdisciplinary Stem Cell Institute (ISCI) at the University of Miami, and co-founder and chief science officer for the stem cell start-up Longeveron, explains the FDA trial for laromestrocel (Lomecel-B) to treat hypoplastic left heart syndrome (HLHS).
The new trial represents a potential breakthrough in the treatment of one of the most devastating congenital heart defects.
READ MORE >

Why patient selection is so important when performing M-TEER

As mitral transcatheter edge-to-edge repair continues to gain momentum in the United States, a new study of CMS data examines what happens to patient outcomes when the procedure fails.

READ MORE >
MitralClip G4 in the Abbott booth at TCT 2023. Photo by Dave Fornell
Share on Twitter Share on Facebook Share on Linkedin

Why patient selection is so important when performing M-TEER

Share on Twitter Share on Facebook Share on Linkedin
MitralClip G4 in the Abbott booth at TCT 2023. Photo by Dave Fornell
As mitral transcatheter edge-to-edge repair continues to gain momentum in the United States, a new study of CMS data examines what happens to patient outcomes when the procedure fails.
READ MORE >

Exploring the link between left ventricular diastolic function and AFib

Evaluating LVDF with echocardiography or AI-powered electrocardiography can help identify individuals at an increased risk of developing atrial fibrillation, according to new data presented at the ASE 36th Annual Scientific Sessions.

READ MORE >
Agfa patient time line of prior exams and echo reporting in its CVIS at ASE 2023.
Share on Twitter Share on Facebook Share on Linkedin

Exploring the link between left ventricular diastolic function and AFib

Share on Twitter Share on Facebook Share on Linkedin
Agfa patient time line of prior exams and echo reporting in its CVIS at ASE 2023.
Evaluating LVDF with echocardiography or AI-powered electrocardiography can help identify individuals at an increased risk of developing atrial fibrillation, according to new data presented at the ASE 36th Annual Scientific Sessions.
READ MORE >

TAVR still a safe option for patients with nickel allergies

More research is still needed, as this study only included data from a small number of patients, but TAVR was not linked to any severe adverse events or allergic reactions.

READ MORE >
The Medtronic CoreValve Evolut and the Edwards Lifesciences Sapien 3 TAVR valves.
Share on Twitter Share on Facebook Share on Linkedin

TAVR still a safe option for patients with nickel allergies

Share on Twitter Share on Facebook Share on Linkedin
The Medtronic CoreValve Evolut and the Edwards Lifesciences Sapien 3 TAVR valves.
More research is still needed, as this study only included data from a small number of patients, but TAVR was not linked to any severe adverse events or allergic reactions.
READ MORE >

In Case You Missed It

FDA details new risk with Johnson & Johnson heart pump controllers after patient’s death

This latest alert was put in place after Johnson & Johnson MedTech learned that some of its Automated Impella Controllers were built to the wrong specifications, impacting their ability to function. Affected devices should not be used going forward.

READ MORE >
Johnson & Johnson MedTech Automated Impella Controller
Share on Twitter Share on Facebook Share on Linkedin

FDA details new risk with Johnson & Johnson heart pump controllers after patient’s death

Share on Twitter Share on Facebook Share on Linkedin
Johnson & Johnson MedTech Automated Impella Controller
This latest alert was put in place after Johnson & Johnson MedTech learned that some of its Automated Impella Controllers were built to the wrong specifications, impacting their ability to function. Affected devices should not be used going forward.
READ MORE >

Oral GLP-1 drug linked to weight loss in patients with and without diabetes—is FDA approval next?

Eli Lilly and Company is back with even more positive data on orforglipron, its oral GLP-1 receptor agonist. The company says it is "moving with urgency" toward gaining key regulatory approvals and getting the drug in the hands of patients.

READ MORE >
Share on Twitter Share on Facebook Share on Linkedin

Oral GLP-1 drug linked to weight loss in patients with and without diabetes—is FDA approval next?

Share on Twitter Share on Facebook Share on Linkedin
Eli Lilly and Company is back with even more positive data on orforglipron, its oral GLP-1 receptor agonist. The company says it is "moving with urgency" toward gaining key regulatory approvals and getting the drug in the hands of patients.
READ MORE >

New York cardiologist headed to prison—DOJ says he paid for referrals, performed unneeded procedures

"Today’s sentence sends a deterrent message to doctors and the healthcare industry," according to a DOJ statement. "If you abuse patient trust for profit, you will face justice."

READ MORE >
court judge gavel business man bankruptcy lawsuit
Share on Twitter Share on Facebook Share on Linkedin

New York cardiologist headed to prison—DOJ says he paid for referrals, performed unneeded procedures

Share on Twitter Share on Facebook Share on Linkedin
court judge gavel business man bankruptcy lawsuit
"Today’s sentence sends a deterrent message to doctors and the healthcare industry," according to a DOJ statement. "If you abuse patient trust for profit, you will face justice."
READ MORE >

In Other News

High school seniors create AI chatbot that understands medical bills

The system, dubbed MedFinanceAI, only works in Nebraska for now. But the three teens behind its development said it can be rolled out into other communities.

READ MORE >
Chatbot
Share on Twitter Share on Facebook Share on Linkedin

High school seniors create AI chatbot that understands medical bills

Share on Twitter Share on Facebook Share on Linkedin
Chatbot
The system, dubbed MedFinanceAI, only works in Nebraska for now. But the three teens behind its development said it can be rolled out into other communities.
READ MORE >

Healthcare AI today: AI-enabled layoffs, following the AI money, AI to unscrew healthcare, more

A network of more than 100 clinics is leveraging AI to lay off more than 175 of its 2,500 or so nonclinical staff by early November.

READ MORE >
laid off artificial intelligence AI in healthcare
Share on Twitter Share on Facebook Share on Linkedin

Healthcare AI today: AI-enabled layoffs, following the AI money, AI to unscrew healthcare, more

Share on Twitter Share on Facebook Share on Linkedin
laid off artificial intelligence AI in healthcare
A network of more than 100 clinics is leveraging AI to lay off more than 175 of its 2,500 or so nonclinical staff by early November.
READ MORE >

Innovate Healthcare thanks our partners for supporting our newsletters.
Sponsorship has no influence on editorial content.

Interested in reaching our audiences, contact our team

*|LIST:ADDRESSLINE|*

You received this email because you signed up for newsletters from Innovate Healthcare.
Change your preferences or unsubscribe here

Contact Us  |  Unsubscribe from all  |  Privacy Policy

© Innovate Healthcare, a TriMed Media brand
Innovate Healthcare

Recent Newsletters

Top 10 most popular cardiology video interviews this past month
Week in Review: New IVL data | TAVR trend prompts 'call to action' | Compensation climbs | Ablations in ASCs | More recalls
News Alert: Thousands of reprocessed EP catheters recalled
New heart failure device impresses | Cardiac amyloidosis in the spotlight | Experts agree: HFmrEF should not be ignored
Cardiology salaries outpace other specialties | A new TAVR technique | Cardiac amyloidosis in the spotlight | BP drug recalled
A new device warning after 3 deaths | AI predicts stroke risk | FDA clears intravascular imaging tech | IV fluids recalled
Top 10 most popular radiology video interviews this past month

Pagination

    • First page « First
    • Previous page ‹‹
    • Page 1
    • Page 2
    • Page 3
    • Page 4
    • Current page 5
    • Page 6
    • Page 7
    • Page 8
    • Page 9 …
    • Next page ››
    • Last page Last »
  • Home
  • News
  • Article Archive
  • Custom Content
  • Webinars
  • Press Releases
  • Content Studio
  • Advertising
  • Submit Press Release
  • Contact Us
  • Terms of Use
  • Privacy Policy
  • Cardiovascular Business
  • HealthExec
  • Radiology Business
 
© 2026 Innovate Healthcare | All Rights Reserved. | Terms of Use | Privacy Policy
 
Design by Adaptive Theme
Trimed Popup